{"license":"https://creativecommons.org/licenses/by/4.0/","dataset":"atlas","updatedThrough":"2026-08-15","guardrail":"The atlas exposes only relationships declared in the current public data. A link or issue grouping does not make unlike measures comparable, establish ownership or control, define an antitrust market, assign liability, or show that a policy event caused an economic outcome.","filters":{"depth":2,"edgeType":"all","edgeTypeMatched":true,"focus":"policy_entity:pent-emisar-pharma","focusMatched":true,"kind":"all","kindMatched":true,"layer":"enforcement","layerMatched":true,"query":"","view":"network"},"summary":{"nodeCount":5478,"edgeCount":19193,"sourceCount":45,"profileCount":5433,"nodeKindCount":13,"layerCount":4,"eligibleEdgeCount":63,"matchedNodeCount":9,"plottedEdgeCount":8,"plottedNodeCount":9,"hiddenNodeCount":0,"directNeighborCount":1},"focusNode":{"id":"policy_entity:pent-emisar-pharma","kind":"policy_entity","label":"Emisar Pharma Services LLC","shortLabel":"Emisar Pharma Servic...","description":"Group purchasing organization named in the FTC insulin administrative complaint record.","href":"/enforcement/entities/emisar-pharma-services-llc","metricLabel":"Named records","metricValue":"1","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"emisar pharma services llc group purchasing organization named in the ftc insulin administrative complaint record. respondent","connectionCount":1},"nodes":[{"id":"policy_entity:pent-emisar-pharma","kind":"policy_entity","label":"Emisar Pharma Services LLC","shortLabel":"Emisar Pharma Servic...","description":"Group purchasing organization named in the FTC insulin administrative complaint record.","href":"/enforcement/entities/emisar-pharma-services-llc","metricLabel":"Named records","metricValue":"1","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"emisar pharma services llc group purchasing organization named in the ftc insulin administrative complaint record. respondent","connectionCount":1,"distance":0,"labelVisible":true,"radius":20,"x":450,"y":260},{"id":"policy_record:evt-pbm-insulin-complaint-2024","kind":"policy_record","label":"FTC files administrative complaint against the three largest PBMs","shortLabel":"FTC files administrative...","description":"The FTC brought an administrative action alleging anticompetitive and unfair rebating and formulary practices involving Caremark, Express Scripts, OptumRx, and affiliated GPOs.","href":"/enforcement/records/pbm-insulin-complaint-2024","metricLabel":"Official stage","metricValue":"litigation","detail":"Federal Trade Commission / 2024-09-20","status":"complaint","year":2024,"color":"#f43f5e","searchText":"evt-pbm-insulin-complaint-2024 ftc files administrative complaint against the three largest pbms federal trade commission complaint litigation the ftc brought an administrative action alleging anticompetitive and unfair rebating and formulary practices involving caremark, express scripts, optumrx, and affiliated gpos. docket no. 9437","connectionCount":8,"x":450,"y":112,"distance":1,"radius":11,"labelVisible":true},{"id":"market:mkt-pbm","kind":"market","label":"U.S. pharmacy benefit management","shortLabel":"PBMs","description":"Pharmacy benefit management services profile based on FTC public findings. The FTC reports top-three and top-six aggregate shares but not enough individual PBM market shares in the public press-release record to compute HHI.","href":"/markets/us-pharmacy-benefit-management","metricLabel":"HHI status","metricValue":"Withheld","detail":"United States / 2023","status":"incomplete","year":2023,"color":"#14b8a6","searchText":"u.s. pharmacy benefit management pbms health care united states pharmacy benefit management services profile based on ftc public findings. the ftc reports top-three and top-six aggregate shares but not enough individual pbm market shares in the public press-release record to compute hhi.","connectionCount":10,"x":471.391,"y":22.963,"distance":2,"radius":8,"labelVisible":false},{"id":"policy_entity:pent-caremark-rx","kind":"policy_entity","label":"Caremark Rx, LLC","shortLabel":"Caremark Rx, LLC","description":"Pharmacy benefit manager named in FTC study and administrative complaint records.","href":"/enforcement/entities/caremark-rx-llc","metricLabel":"Named records","metricValue":"3","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"caremark rx, llc pharmacy benefit manager named in ftc study and administrative complaint records. report_subject respondent remedy_subject","connectionCount":3,"x":648.66,"y":128.934,"distance":2,"radius":8,"labelVisible":false},{"id":"policy_entity:pent-express-scripts","kind":"policy_entity","label":"Express Scripts, Inc.","shortLabel":"Express Scripts, Inc.","description":"Pharmacy benefit manager named in FTC study and administrative complaint records.","href":"/enforcement/entities/express-scripts-inc","metricLabel":"Named records","metricValue":"3","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"express scripts, inc. pharmacy benefit manager named in ftc study and administrative complaint records. report_subject respondent remedy_subject","connectionCount":3,"x":676.334,"y":333.6,"distance":2,"radius":8,"labelVisible":false},{"id":"policy_entity:pent-ascent-health","kind":"policy_entity","label":"Ascent Health Services, LLC","shortLabel":"Ascent Health Servic...","description":"Group purchasing organization named in the FTC insulin administrative complaint record.","href":"/enforcement/entities/ascent-health-services-llc","metricLabel":"Named records","metricValue":"2","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"ascent health services, llc group purchasing organization named in the ftc insulin administrative complaint record. respondent remedy_subject","connectionCount":2,"x":533.574,"y":482.844,"distance":2,"radius":8,"labelVisible":false},{"id":"policy_entity:pent-optumrx","kind":"policy_entity","label":"OptumRx, Inc.","shortLabel":"OptumRx, Inc.","description":"Pharmacy benefit manager named in FTC study and administrative complaint records.","href":"/enforcement/entities/optumrx-inc","metricLabel":"Named records","metricValue":"2","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"optumrx, inc. pharmacy benefit manager named in ftc study and administrative complaint records. report_subject respondent","connectionCount":2,"x":327.881,"y":464.281,"distance":2,"radius":8,"labelVisible":false},{"id":"policy_entity:pent-zinc-health","kind":"policy_entity","label":"Zinc Health Services, LLC","shortLabel":"Zinc Health Services...","description":"Group purchasing organization named in the FTC insulin administrative complaint record.","href":"/enforcement/entities/zinc-health-services-llc","metricLabel":"Named records","metricValue":"2","detail":"Official-record organization label","status":"record-only label","year":null,"color":"#ec4899","searchText":"zinc health services, llc group purchasing organization named in the ftc insulin administrative complaint record. respondent remedy_subject","connectionCount":2,"x":214.146,"y":291.891,"distance":2,"radius":8,"labelVisible":false},{"id":"source:ftc-pbm-insulin-complaint-2024","kind":"source","label":"FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices","shortLabel":"Federal Trade Commission","description":"FTC administrative complaint record concerning alleged rebating and formulary practices by the three largest PBMs and affiliated GPOs.","href":"/sources/ftc-pbm-insulin-complaint-2024","metricLabel":"Access date","metricValue":"2026-07-17","detail":"Federal Trade Commission","status":"agency report","year":2026,"color":"#64748b","searchText":"ftc-pbm-insulin-complaint-2024 ftc sues prescription drug middlemen for artificially inflating insulin drug prices federal trade commission ftc administrative complaint record concerning alleged rebating and formulary practices by the three largest pbms and affiliated gpos. federal trade commission, ftc sues prescription drug middlemen for artificially inflating insulin drug prices, september 20 2024. agency_report","connectionCount":1,"x":278.014,"y":95.486,"distance":2,"radius":8,"labelVisible":false}],"rows":[{"id":"named-in-record:peel-ascent-complaint","layer":"enforcement","relationshipType":"named_in_record","relationshipLabel":"respondent","fromId":"policy_record:evt-pbm-insulin-complaint-2024","fromKind":"policy_record","fromLabel":"FTC files administrative complaint against the three largest PBMs","fromHref":"/enforcement/records/pbm-insulin-complaint-2024","toId":"policy_entity:pent-ascent-health","toKind":"policy_entity","toLabel":"Ascent Health Services, LLC","toHref":"/enforcement/entities/ascent-health-services-llc","evidenceLabel":"Exact official-record relationship","evidenceDetail":"The FTC administrative complaint names affiliated GPO Ascent Health Services as a respondent.","sourceId":"ftc-pbm-insulin-complaint-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A named-organization edge records the role encoded from one official record; it is not an independent liability or identity finding."},{"id":"named-in-record:peel-caremark-complaint","layer":"enforcement","relationshipType":"named_in_record","relationshipLabel":"respondent","fromId":"policy_record:evt-pbm-insulin-complaint-2024","fromKind":"policy_record","fromLabel":"FTC files administrative complaint against the three largest PBMs","fromHref":"/enforcement/records/pbm-insulin-complaint-2024","toId":"policy_entity:pent-caremark-rx","toKind":"policy_entity","toLabel":"Caremark Rx, LLC","toHref":"/enforcement/entities/caremark-rx-llc","evidenceLabel":"Exact official-record relationship","evidenceDetail":"The FTC administrative complaint names Caremark Rx as a respondent.","sourceId":"ftc-pbm-insulin-complaint-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A named-organization edge records the role encoded from one official record; it is not an independent liability or identity finding."},{"id":"named-in-record:peel-emisar-complaint","layer":"enforcement","relationshipType":"named_in_record","relationshipLabel":"respondent","fromId":"policy_record:evt-pbm-insulin-complaint-2024","fromKind":"policy_record","fromLabel":"FTC files administrative complaint against the three largest PBMs","fromHref":"/enforcement/records/pbm-insulin-complaint-2024","toId":"policy_entity:pent-emisar-pharma","toKind":"policy_entity","toLabel":"Emisar Pharma Services LLC","toHref":"/enforcement/entities/emisar-pharma-services-llc","evidenceLabel":"Exact official-record relationship","evidenceDetail":"The FTC administrative complaint names affiliated GPO Emisar Pharma Services as a respondent.","sourceId":"ftc-pbm-insulin-complaint-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A named-organization edge records the role encoded from one official record; it is not an independent liability or identity finding."},{"id":"named-in-record:peel-express-scripts-complaint","layer":"enforcement","relationshipType":"named_in_record","relationshipLabel":"respondent","fromId":"policy_record:evt-pbm-insulin-complaint-2024","fromKind":"policy_record","fromLabel":"FTC files administrative complaint against the three largest PBMs","fromHref":"/enforcement/records/pbm-insulin-complaint-2024","toId":"policy_entity:pent-express-scripts","toKind":"policy_entity","toLabel":"Express Scripts, Inc.","toHref":"/enforcement/entities/express-scripts-inc","evidenceLabel":"Exact official-record relationship","evidenceDetail":"The FTC administrative complaint names Express Scripts as a respondent.","sourceId":"ftc-pbm-insulin-complaint-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A named-organization edge records the role encoded from one official record; it is not an independent liability or identity finding."},{"id":"named-in-record:peel-optumrx-complaint","layer":"enforcement","relationshipType":"named_in_record","relationshipLabel":"respondent","fromId":"policy_record:evt-pbm-insulin-complaint-2024","fromKind":"policy_record","fromLabel":"FTC files administrative complaint against the three largest PBMs","fromHref":"/enforcement/records/pbm-insulin-complaint-2024","toId":"policy_entity:pent-optumrx","toKind":"policy_entity","toLabel":"OptumRx, Inc.","toHref":"/enforcement/entities/optumrx-inc","evidenceLabel":"Exact official-record relationship","evidenceDetail":"The FTC administrative complaint names OptumRx as a respondent.","sourceId":"ftc-pbm-insulin-complaint-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A named-organization edge records the role encoded from one official record; it is not an independent liability or identity finding."},{"id":"named-in-record:peel-zinc-complaint","layer":"enforcement","relationshipType":"named_in_record","relationshipLabel":"respondent","fromId":"policy_record:evt-pbm-insulin-complaint-2024","fromKind":"policy_record","fromLabel":"FTC files administrative complaint against the three largest PBMs","fromHref":"/enforcement/records/pbm-insulin-complaint-2024","toId":"policy_entity:pent-zinc-health","toKind":"policy_entity","toLabel":"Zinc Health Services, LLC","toHref":"/enforcement/entities/zinc-health-services-llc","evidenceLabel":"Exact official-record relationship","evidenceDetail":"The FTC administrative complaint names affiliated GPO Zinc Health Services as a respondent.","sourceId":"ftc-pbm-insulin-complaint-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A named-organization edge records the role encoded from one official record; it is not an independent liability or identity finding."},{"id":"policy-scope:evt-pbm-insulin-complaint-2024:mkt-pbm","layer":"enforcement","relationshipType":"policy_scope","relationshipLabel":"Related policy context","fromId":"market:mkt-pbm","fromKind":"market","fromLabel":"U.S. pharmacy benefit management","fromHref":"/markets/us-pharmacy-benefit-management","toId":"policy_record:evt-pbm-insulin-complaint-2024","toKind":"policy_record","toLabel":"FTC files administrative complaint against the three largest PBMs","toHref":"/enforcement/records/pbm-insulin-complaint-2024","evidenceLabel":"Federal Trade Commission / 2024-09-20","evidenceDetail":"Adds alleged conduct and patient-harm context to the PBM profile. The allegations remain distinct from the descriptive concentration evidence and do not supply missing individual shares.","sourceId":"ftc-pbm-insulin-complaint-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","confidenceLevel":"bounded","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"A related-market edge records the observatory's bounded context for a dated official event; it does not show causal effects on concentration."},{"id":"record-source:evt-pbm-insulin-complaint-2024:ftc-pbm-insulin-complaint-2024","layer":"enforcement","relationshipType":"record_source","relationshipLabel":"Official record source","fromId":"policy_record:evt-pbm-insulin-complaint-2024","fromKind":"policy_record","fromLabel":"FTC files administrative complaint against the three largest PBMs","fromHref":"/enforcement/records/pbm-insulin-complaint-2024","toId":"source:ftc-pbm-insulin-complaint-2024","toKind":"source","toLabel":"FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices","toHref":"/sources/ftc-pbm-insulin-complaint-2024","evidenceLabel":"Federal Trade Commission","evidenceDetail":"FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices is the custody record encoded for this dated policy event.","sourceId":"ftc-pbm-insulin-complaint-2024","sourceUrl":"https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-sues-prescription-drug-middlemen-artificially-inflating-insulin-drug-prices","confidenceLevel":"high","indicatorId":null,"entityCode":null,"observationCount":null,"firstYear":null,"latestYear":null,"preferredView":null,"sourceIds":null,"guardrail":"The source is the official custody record for the encoded event; later outcomes require separate evidence."}]}